2022
DOI: 10.7150/ijbs.75303
|View full text |Cite
|
Sign up to set email alerts
|

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer: Retraction

Abstract: The authors recently found that some results were not repeatable in the cell lines and needed further verifications. After careful consideration, the authors decided to retract this article. All authors have agreed to the retraction of the article, and apologize for any inconvenience caused.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In addition, NEK2 may also play a role in microtubule stabilization [70], B cell development and immunological response [71], and splicing [72]. NEK2 overexpression has been found in various human malignancies [73][74][75][76][77][78][79][80], including gastrointestinal tumors [81,82]. Aberrant NEK2 expression in cancers has been associated with tumor cell proliferation [83], migration [82], invasion [74,77], drug/radio resistance [84,85], immune response [80,86], and poor prognosis [26,75].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, NEK2 may also play a role in microtubule stabilization [70], B cell development and immunological response [71], and splicing [72]. NEK2 overexpression has been found in various human malignancies [73][74][75][76][77][78][79][80], including gastrointestinal tumors [81,82]. Aberrant NEK2 expression in cancers has been associated with tumor cell proliferation [83], migration [82], invasion [74,77], drug/radio resistance [84,85], immune response [80,86], and poor prognosis [26,75].…”
Section: Discussionmentioning
confidence: 99%
“…Lung cancer is a malignant tumor originating from the epithelium or glands of the bronchial mucosa (Bai et al, 2022). Chemotherapy, radiation therapy, targeted biological therapy, and immunotherapy are the current methods for treating lung cancer (Mazloum-Ravasan et al, 2022).…”
Section: Lung Cancermentioning
confidence: 99%